Related references
Note: Only part of the references are listed.Effects of CGRP receptor antagonism on glucose and bone metabolism in mice with diet-induced obesity
Paul Koehli et al.
BONE (2021)
Acute Increase in Blood αCGRP at Maximal Exercise and Its Association to Cardiorespiratory Fitness, Carbohydrate Oxidation and Work Performed: An Exploratory Study in Young Men
Adolfo Aracil-Marco et al.
BIOLOGY-BASEL (2021)
Trend analysis of cardiovascular disease mortality, incidence, and mortality-to-incidence ratio: results from global burden of disease study 2017
Maedeh Amini et al.
BMC PUBLIC HEALTH (2021)
Heart Disease and Stroke Statistics-2021 Update A Report From the American Heart Association
Salim S. Virani et al.
CIRCULATION (2021)
Calcitonin Gene-Related Peptide Protects Against Cardiovascular Dysfunction Independently of Nitric Oxide In Vivo
Fulye Argunhan et al.
HYPERTENSION (2021)
CGRP derived from cardiac fibroblasts is an endogenous suppressor of cardiac fibrosis
Wenqun Li et al.
CARDIOVASCULAR RESEARCH (2020)
Effects of endurance exercise on serum concentration of calcitonin gene-related peptide (CGRP): a potential link between exercise intensity and headache
Cantor Tarperi et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2020)
Anti-migraine Calcitonin Gene-Related Peptide Receptor Antagonists Worsen Cerebral Ischemic Outcome in Mice
Inge A. Mulder et al.
ANNALS OF NEUROLOGY (2020)
CGRP inhibitors for migraine prophylaxis: a safety review
Eduardo Rivera-Mancilla et al.
EXPERT OPINION ON DRUG SAFETY (2020)
Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019 Update From the GBD 2019 Study
Gregory A. Roth et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Safety and tolerability of calcitonin-gene-related peptide binding monoclonal antibodies for the prevention of episodic migraine - a meta-analysis of randomized controlled trials
Da Xu et al.
CEPHALALGIA (2019)
Safety and Tolerability of Fremanezumab for the Prevention of Migraine: A Pooled Analysis of Phases 2b and 3 Clinical Trials
Stephen D. Silberstein et al.
HEADACHE (2019)
Long-term safety and tolerability of erenumab: Three-plus year results from a five-year open-label extension study in episodic migraine
Messoud Ashina et al.
CEPHALALGIA (2019)
Ischemic Stroke Associated With Calcitonin Gene-Related Peptide Inhibitor Therapy for Migraine: A Case Report
Stephen Aradi et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2019)
Fremanezumab versus placebo for migraine prevention in patients with documented failure to up to four migraine preventive medication classes (FOCUS): a randomised, double-blind, placebo-controlled, phase 3b trial
Michel D. Ferrari et al.
LANCET (2019)
Blood Pressure Normalization-Independent Cardioprotective Effects of Endogenous, Physical Activity-Induced αCGRP (α Calcitonin Gene-Related Peptide) in Chronically Hypertensive Mice
Tom Skaria et al.
CIRCULATION RESEARCH (2019)
Effects of Exercise to Improve Cardiovascular Health
Kelsey Pinckard et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2019)
Efficacy and safety of galcanezumab for the prevention of episodic migraine: Results of the EVOLVE-2 Phase 3 randomized controlled clinical trial
Vladimir Skljarevski et al.
CEPHALALGIA (2018)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Erenumab on Exercise Time During a Treadmill Test in Patients With Stable Angina
Christophe Depre et al.
HEADACHE (2018)
Cryo-EM structure of the active, G(s)- protein complexed, human CGRP receptor
Yi-Lynn Liang et al.
NATURE (2018)
Exercise benefits in cardiovascular disease: beyond attenuation of traditional risk factors
Carmen Fiuza-Luces et al.
NATURE REVIEWS CARDIOLOGY (2018)
Is CGRP Receptor Blockade Cardiovascularly Safe? Appropriate Studies Are Needed
A. Maassen van den Brink et al.
HEADACHE (2018)
Serum calcitonin gene-related peptide facilitates adipose tissue lipolysis during exercise via PIPLC/IP3 pathways
Malihe Aveseh et al.
ENDOCRINE (2018)
Endogenous Calcitonin Gene-Related Peptide Regulates Lipid Metabolism and Energy Homeostasis in Male Mice
Tian Liu et al.
ENDOCRINOLOGY (2017)
Molecular Mechanisms Underlying Cardiac Adaptation to Exercise
Rick B. Vega et al.
CELL METABOLISM (2017)
Long acting analogue of the calcitonin gene-related peptide induces positive metabolic effects and secretion of the glucagon-like peptide-1
Cecilia Nilsson et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2016)
Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trial
Hong Sun et al.
LANCET NEUROLOGY (2016)
Wiping Out CGRP: Potential Cardiovascular Risks
Antoinette MaassenVanDenBrink et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2016)
Emerging Relationships between Exercise, Sensory Nerves, and Neuropathic Pain
Michael A. Cooper et al.
FRONTIERS IN NEUROSCIENCE (2016)
Endogenous α-calcitonin-gene-related peptide promotes exercise-induced, physiological heart hypertrophy in mice
B. Schuler et al.
ACTA PHYSIOLOGICA (2014)
Monoclonal Antibodies for Migraine: Preventing Calcitonin Gene-Related Peptide Activity
Marcelo E. Bigal et al.
CNS DRUGS (2014)
CALCITONIN GENE-RELATED PEPTIDE: PHYSIOLOGY AND PATHOPHYSIOLOGY
F. A. Russell et al.
PHYSIOLOGICAL REVIEWS (2014)
Inotropic and lusitropic effects of calcitonin gene-related peptide in the heart
Mustafa Al-Rubaiee et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2013)
Cardiorespiratory Fitness as a Quantitative Predictor of All-Cause Mortality and Cardiovascular Events in Healthy Men and Women A Meta-analysis
Satoru Kodama et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Evidence that alpha-calcitonin gene-related peptide is a neurohormone that controls systemic lipid availability and utilization
Rachel N. Danaher et al.
ENDOCRINOLOGY (2008)
Antiapoptotic effect of calcitonin gene-related peptide on oxidative stress-induced injury in H9c2 cardiomyocytes via the RAMP1/CRLR complex
S Sueur et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2005)
Calcitonin gene-related peptide protects against hypertension-induced heart and kidney damage
SC Supowit et al.
HYPERTENSION (2005)
Investigation of CGRP receptors and peptide pharmacology in human coronary arteries. Characterization with a nonpeptide antagonist
P Hasbak et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Calcitonin gene-related peptide and adrenomedullin release in humans: Effects of exercise and hypoxia
P Hasbak et al.
REGULATORY PEPTIDES (2002)
Share Paper
